{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:40:35Z","timestamp":1789501235163,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.intimp.2025.115069","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T07:51:46Z","timestamp":1749541906000},"page":"115069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Mucosal-associated invariant T cells in diabetes mellitus: Protective or destructive?"],"prefix":"10.1016","volume":"161","author":[{"given":"Mahvash","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Dehnavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Mohammad","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.intimp.2025.115069_bb0005","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","article-title":"The biology and functional importance of MAIT cells","volume":"20","author":"Godfrey","year":"2019","journal-title":"Nat. Immunol."},{"issue":"6928","key":"10.1016\/j.intimp.2025.115069_bb0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature01433","article-title":"Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1","volume":"422","author":"Treiner","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2025.115069_bb0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1570161117666190405165911","article-title":"The growing epidemic of diabetes mellitus","volume":"18","author":"Lovic","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"46","key":"10.1016\/j.intimp.2025.115069_bb0020","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000040412","article-title":"Exploring the causal relationships between type 2 diabetes and neurological disorders using a Mendelian randomization strategy","volume":"103","author":"Wei","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.intimp.2025.115069_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1573403X1604201229115531","article-title":"Complications of the type 2 diabetes mellitus","volume":"16","author":"Farmaki","year":"2020","journal-title":"Curr. Cardiol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2025.115069_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.intimp.2025.115069_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s10020-024-00824-9","article-title":"An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory","volume":"30","author":"Yang","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2025.115069_bb0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fimmu.2015.00341","article-title":"iNKT and MAIT cell alterations in diabetes","volume":"6","author":"Magalhaes","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115069_bb0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fendo.2017.00343","article-title":"T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes","volume":"8","author":"Burrack","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115069_bb0050","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.mjt.0000178767.67857.63","article-title":"Autoimmune destruction of pancreatic \u03b2 cells","volume":"12","author":"Yoon","year":"2005","journal-title":"Am. J. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2025.115069_bb0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5897\/JPAP2013.0001","article-title":"The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus","volume":"4","author":"Ozougwu","year":"2013","journal-title":"J. Physiol. Pathophysiol."},{"issue":"17","key":"10.1016\/j.intimp.2025.115069_bb0060","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115069_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.178.1.1","article-title":"Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8-alpha\/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain","volume":"178","author":"Porcelli","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.115069_bb0070","article-title":"MAIT cells in metabolic diseases","volume":"27","author":"Bertrand","year":"2019","journal-title":"Mol. Metabo."},{"key":"10.1016\/j.intimp.2025.115069_bb0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.molimm.2020.12.017","article-title":"Biological functions of MAIT cells in tissues","volume":"130","author":"Klenerman","year":"2021","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115069_bb0080","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1084\/jem.20142110","article-title":"Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers","volume":"212","author":"Rahimpour","year":"2015","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.intimp.2025.115069_bb0085","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ni.3565","article-title":"A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage","volume":"17","author":"Koay","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.115069_bb0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coi.2017.04.002","article-title":"MAIT cells and MR1-antigen recognition","volume":"46","author":"Keller","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115069_bb0095","doi-asserted-by":"crossref","first-page":"2350483","DOI":"10.1002\/eji.202350483","article-title":"MAIT cells in immune-mediated tissue injury and repair","volume":"53","author":"Waterh\u00f6lter","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115069_bb0100","first-page":"1250","article-title":"Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17\u2013secreting T cells","volume":"117","author":"Dusseaux","year":"2011","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.intimp.2025.115069_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2020.12.003","article-title":"MAIT cell development in mice and humans","volume":"130","author":"Salou","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115069_bb0110","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3389\/fimmu.2018.01333","article-title":"Mucosal-associated invariant T cells in autoimmune diseases","volume":"9","author":"Chiba","year":"2018","journal-title":"Front. Immunol."},{"issue":"7426","key":"10.1016\/j.intimp.2025.115069_bb0115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature11605","article-title":"MR1 presents microbial vitamin B metabolites to MAIT cells","volume":"491","author":"Kjer-Nielsen","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2025.115069_bb0120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/ni.3679","article-title":"Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells","volume":"18","author":"Keller","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.115069_bb0125","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3389\/fimmu.2020.01014","article-title":"MAIT cell activation and functions","volume":"11","author":"Hinks","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115069_bb0130","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1128\/IAI.00279-12","article-title":"Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection","volume":"80","author":"Chua","year":"2012","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2025.115069_bb0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/eji.201343509","article-title":"CD 161++ CD 8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+ IL-18 in a TCR-independent manner","volume":"44","author":"Ussher","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115069_bb0140","doi-asserted-by":"crossref","first-page":"11653","DOI":"10.1038\/ncomms11653","article-title":"MAIT cells are activated during human viral infections","volume":"7","author":"Van Wilgenburg","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2025.115069_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2001930","volume":"15","author":"Shaler","year":"2017","journal-title":"PLoS Biol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115069_bb0150","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41577-019-0191-y","article-title":"Mucosal-associated invariant T cells and disease","volume":"19","author":"Toubal","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115069_bb0155","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.celrep.2019.08.054","article-title":"TCR-or cytokine-activated CD8+ mucosal-associated invariant T cells are rapid polyfunctional effectors that can coordinate immune responses","volume":"28","author":"Lamichhane","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.intimp.2025.115069_bb0160","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.4049\/jimmunol.1701512","article-title":"Mucosal-associated invariant T cells augment immunopathology and gastritis in chronic helicobacter pylori infection","volume":"200","author":"D\u2019Souza","year":"2018","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115069_bb0165","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1016\/j.celrep.2019.08.050","article-title":"TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions","volume":"28","author":"Leng","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2025.115069_bb0170","article-title":"MAIT cells are imprinted by the microbiota in early life and promote tissue repair","volume":"366(6464):eaax6624","author":"Constantinides","year":"2019","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.intimp.2025.115069_bb0175","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221939","article-title":"Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses","volume":"220","author":"Chancellor","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.115069_bb0180","article-title":"Self-reactive MAIT cells are common in healthy individuals","volume":"23(9):543","author":"Flemming","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115069_bb0185","article-title":"Role of mucosal-associated invariant T cells dynamics in pathogenesis of Sj\u00f6gren syndrome","volume":"14(1):17256","author":"Chauffier","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.115069_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114250","article-title":"New insights into MAIT cells in autoimmune diseases","volume":"159","author":"Fan","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2025.115069_bb0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/intimm\/dxh018","article-title":"2\u2013J\u03b133 invariant T cells in human autoimmune inflammatory lesions in the nervous system","volume":"16","author":"Ill\u00e9s","year":"2004","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115069_bb0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/art.33314","article-title":"Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis","volume":"64","author":"Chiba","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.intimp.2025.115069_bb0205","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ni.3854","article-title":"Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes","volume":"18","author":"Rouxel","year":"2017","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115069_bb0210","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/ni.3869","article-title":"MAIT cells in type 1 diabetes: a good friend turned bad","volume":"18","author":"Petersone","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.115069_bb0215","doi-asserted-by":"crossref","unstructured":"Rouxel O, Da Silva J, Beaudoin L, Nel I, Tard C, Cagninacci L, Kiaf B, Oshima M, Diedisheim M, Salou M, Corbett A, Rossjohn J, McCluskey J, Scharfmann R, Battaglia M, Polak M, Lantz O, Beltrand J, Lehuen A. Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes. Nat Immunol. 2017 Dec;18(12):1321-1331. doi: 10.1038\/ni.3854. Epub 2017 Oct 9. Erratum in: Nat Immunol. 2018 Sep;19(9):1035. doi: 10.1038\/s41590-017-0023-9. PMID: 28991267; PMCID: PMC6025738.","DOI":"10.1038\/ni.3854"},{"issue":"1","key":"10.1016\/j.intimp.2025.115069_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117335","article-title":"Altered CD161bright CD8+ mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics","volume":"10","author":"Harms","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.intimp.2025.115069_bb0225","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cmet.2017.11.007","article-title":"MAIT cells: a link between gut integrity and type 1 diabetes","volume":"26","author":"G\u00fclden","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2025.115069_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.604157","article-title":"Frequencies of CD8 and DN MAIT cells among children diagnosed with type 1 diabetes are similar to age-matched controls","volume":"12","author":"Harms","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115069_bb0235","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00125-020-05257-7","article-title":"Mucosal-associated invariant T cell alterations during the development of human type 1 diabetes","volume":"63","author":"Gazali","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2025.115069_bb0240","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.3389\/fimmu.2018.02332","article-title":"Abnormal T cell frequencies, including cytomegalovirus-associated expansions, distinguish seroconverted subjects at risk for type 1 diabetes","volume":"9","author":"Harms","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115069_bb0245","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1007\/s00125-021-05527-y","article-title":"MAIT cell alterations in adults with recent-onset and long-term type 1 diabetes","volume":"64","author":"Nel","year":"2021","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.intimp.2025.115069_bb0250","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1093\/ejendo\/lvae002","article-title":"Insulitis in human type 1 diabetes: lessons from an enigmatic lesion","volume":"190","author":"Morgan","year":"2024","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115069_bb0255","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ajpath.2018.04.009","article-title":"No evidence for presence of mucosal-associated invariant T cells in the insulitic lesions in patients recently diagnosed with type 1 diabetes","volume":"188","author":"Kuric","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"18","key":"10.1016\/j.intimp.2025.115069_bb0260","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147474","article-title":"The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.intimp.2025.115069_bb0265","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1038\/s41467-022-34162-3","article-title":"Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115069_bb0270","article-title":"Systemic evaluation of the effect of diabetes mellitus on breast cancer in a mouse model","volume":"12","author":"Wei","year":"2022","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115069_bb0275","doi-asserted-by":"crossref","first-page":"11641","DOI":"10.1002\/cam4.5868","article-title":"Impacts of pre-existing diabetes mellitus on colorectal cancer in a mice model","volume":"12","author":"Lv","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.intimp.2025.115069_bb0280","doi-asserted-by":"crossref","first-page":"1397661","DOI":"10.3389\/fendo.2024.1397661","article-title":"Single-cell analysis of human PBMCs in healthy and type 2 diabetes populations: dysregulated immune networks in type 2 diabetes unveiled through single-cell profiling","volume":"15","author":"Gu","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115069_bb0285","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI78941","article-title":"Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients","volume":"125","author":"Magalhaes","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.intimp.2025.115069_bb0290","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00125-022-05682-w","article-title":"Mucosal-associated invariant T cells are associated with insulin resistance in childhood obesity, and disrupt insulin signalling via IL-17","volume":"65","author":"Bergin","year":"2022","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.intimp.2025.115069_bb0295","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.4049\/jimmunol.1402945","article-title":"Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity","volume":"194","author":"Carolan","year":"2015","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115069_bb0300","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.4049\/jimmunol.1801600","article-title":"Obesity reduces mTORC1 activity in mucosal-associated invariant T cells, driving defective metabolic and functional responses","volume":"202","author":"O\u2019Brien","year":"2019","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115069_bb0305","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1096\/fj.201800052RR","article-title":"Mucosal-associated invariant T (MAIT) cells are depleted and prone to apoptosis in cardiometabolic disorders","volume":"32","author":"Touch","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2025.115069_bb0310","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fimmu.2020.01582","article-title":"The effects of type 2 diabetes mellitus on organ metabolism and the immune system","volume":"11","author":"Daryabor","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115069_bb0315","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00125-013-3116-5","article-title":"Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes","volume":"57","author":"Butcher","year":"2014","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.intimp.2025.115069_bb0320","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.2337\/db13-1511","article-title":"T cell\u2013derived IL-22 amplifies IL-1\u03b2\u2013driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes","volume":"63","author":"Dalmas","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.intimp.2025.115069_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3620","article-title":"Th1 bias of liver mucosal-associated invariant T cells promotes hepatic gluconeogenesis in type 2 diabetes mellitus","volume":"39","author":"Tang","year":"2023","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2025.115069_bb0330","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2370616","article-title":"Oral histidine affects gut microbiota and MAIT cells improving glycemic control in type 2 diabetes patients","volume":"16","author":"Warmbrunn","year":"2024","journal-title":"Gut Microbes"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T19:57:33Z","timestamp":1775764653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925010598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":66,"alternative-id":["S1567576925010598"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115069","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal-associated invariant T cells in diabetes mellitus: Protective or destructive?","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115069"}}